The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
about
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?Muscarinic antagonists in early stage clinical development for the treatment of asthma.One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study.Safety of inhaled long-acting anti-muscarinic agents in COPD.
P2860
The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The safety of anticholinergic ...... obstructive pulmonary disease.
@en
type
label
The safety of anticholinergic ...... obstructive pulmonary disease.
@en
prefLabel
The safety of anticholinergic ...... obstructive pulmonary disease.
@en
P2860
P1476
The safety of anticholinergic ...... obstructive pulmonary disease.
@en
P2093
D P Tashkin
P2860
P304
P356
10.1517/14740338.2015.1093621
P407
P577
2015-09-24T00:00:00Z